Matoke Holdings

Matoke Holdings is a biotechnology company in the business of developing a generation of antimicrobials based on its Reactive Oxygen technology platform. Our aim is to address the growing threat of antimicrobial resistance worldwide - a condition predicted to claim over a million lives every year. To date, numerous multi-drug resistant strains have survived contact with our Reactive Oxygen species and technology.

We have partnered with renowned researchers at British universities and teaching hospitals to continue in developing a platform for ROS Reactive Oxygen species. WIth this, we envision to take biotechnology into the heart of where antibiotics have been failing.

Matoke Holdings is a biotechnology company in the business of developing a generation of antimicrobials based on its Reactive Oxygen technology platform. Our aim is to address the growing threat of antimicrobial resistance worldwide - a condition predicted to claim over a million lives every year. To date, numerous multi-drug resistant strains have survived contact with our Reactive Oxygen species and technology.

We have partnered with renowned researchers at British universities and teaching hospitals to continue in developing a platform for ROS Reactive Oxygen species. WIth this, we envision to take biotechnology into the heart of where antibiotics have been failing.